Cafepharma Today

September 18 2024 - FDA scraps adcomm for Applied's rare disease drug ahead of November decision
FDA scraps adcomm for Applied's rare disease drug ahead of November decision
Ascendis trial data piles pressure on BioMarin
Agency warns J&J over 340B rebate plan
GSK touts co-administration data for RSV, shingles vaccines
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Amgen is poised for higher opening following approval of rare blood-clotting disorder drug
Yahoo/AP
Monday, August 25, 2008 - 9:16am
tags:
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Yahoo
Monday, August 25, 2008 - 7:48am
tags:
Glaxo's HIV-Drug Ads Draw Critics
WSJ Online
Monday, August 25, 2008 - 6:06am
tags:
Ranbaxy Falls After Dow Says India to Review Purchase
Bloomberg
Monday, August 25, 2008 - 5:56am
tags:
Nicox says Pfizer drops glaucoma drug study in Asia
Yahoo/Reuters
Monday, August 25, 2008 - 5:55am
tags:
Eisai Wins U.S. Approval to Sell Nausea Drug Aloxi in Capsules
Bloomberg
Sunday, August 24, 2008 - 10:16pm
tags:
The Long Case for Pfizer
Seeking Alpha
Sunday, August 24, 2008 - 4:00pm
tags:
Dr Reddy's plans to brand US speciality drugs
Business Standard, India
Sunday, August 24, 2008 - 10:32am
tags:
Antibody Engineering Cuts the Collateral Damage of Cancer Drugs
Wired News
Sunday, August 24, 2008 - 10:30am
tags:
New FDA labels may protect drug makers
The News Journal, DE
Sunday, August 24, 2008 - 10:23am
tags:
FDA Approves ALOXI(R) (Palonosetron HCl) Capsules For Prevention Of Acute Chemotherapy Induced Nausea And Vomiting
Medical News Today
Sunday, August 24, 2008 - 10:22am
tags:
Long Uphill Climb Continues For Genetics Firms
Yahoo/Investors Business Daily
Saturday, August 23, 2008 - 2:07pm
tags:
Don't Worry About Vytorin's Cancer Risk
Motley Fool
Saturday, August 23, 2008 - 10:47am
tags:
Salix Pharmaceuticals Sells $60 Million Of Convertible Notes
Trading Markets
Saturday, August 23, 2008 - 10:43am
tags:
GSK to provide public with more information
San Antonio Business Journal, TX
Saturday, August 23, 2008 - 10:42am
tags:
PharmaGap Closes $1.1 million Public Portion of Anticipated $2.6 million Equity Financing; Announces Full Clinical Development Group to Take Lead Cancer Drug into Human Clinical Trials
CNW Telbec
Saturday, August 23, 2008 - 10:41am
tags:
Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
CNW Telbec, Canada
Saturday, August 23, 2008 - 10:39am
tags:
FDA wants clear drug labels
Allentown Morning Call, PA
Saturday, August 23, 2008 - 10:37am
tags:
Owning Abbott shares a 'badge of honor'
Waukegan News Sun, IL
Saturday, August 23, 2008 - 10:35am
tags:
Cymbalta Receives European Approval For The Treatment Of Generalised Anxiety Disorder
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

FDA Approves Fasenra for Eosinophilic Granulomatosis with Polyangiitis
pharmexec
FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
pharmexec
Keytruda Demonstrates Superior Overall Survival vs. Yervoy in Advanced Melanoma
pharmexec
CAR-T For Autoimmune Disorders
In the Pipeline
A Better Response to Inflammation: Q&A with Dr. Ira Spector
pharmexec
Braftovi Plus Mektovi Demonstrates Sustained Efficiency in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
pharmexec
GSK Launches Brooke Shields’ Led Campaign Promoting Shingles Vaccine
pharmexec
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
pharmexec
Pharmaceutical Executive: September 2024 Issue (PDF)
pharmexec

Latest Jobs

Account Manager-Los Angeles-Ophthalmics
Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Regional Sales Manager - Eyecare - East Region
Miami, Florida, 33222
PV8 US Innovex Inc.
Business Development Manager- Tampa, Florida
Tampa, Florida, 33646
Hanger Clinic
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
Territory Account Associate- Grand Rapids, MI
Grand Rapids, Michigan, 49528
Amplity Health
Surgical Solutions Field Sales Associate - Remote
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Manager, Business Development - Physician Relations - Days - Full-Time
Baton Rouge, Louisiana, 70873
Woman's Hospital
Area Business Manager - Pulmonology - Greenville, SC
Asheville, North Carolina, 28814
Sanofi
Area Manager, Specialty Atlantic Region
Fields, Oregon, 97710
CSL Behring
Territory Manager (PCP) (Madison, AL)
Huntsville, Alabama, 35824
Bausch Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information